Sign In
Stock Market
Dr Reddy’s Stock Tanks 7% Post-Q3 Earnings
Dr Reddy’s Shares Tumbles After Missing Q3 Estimates
Pharma
Dr Reddy's Launches Drug To Treat Rare Form Of Cancer
IPO-Bound Senores, Dr Reddy’s Launch Ivermectin Tablets
IPO
IPO-bound Senores Pharma, Dr. Reddy's Labs launch ivermectin tablets in US
Dr Reddy’s, FDC Recall Products In US Over Mfg Issues
National
Nestle India Transfers Medical Nutrition Business to Dr Reddy’s JV for ₹218.9 Crore
Telangana State
Dr Reddy’s biosimilar cancer drug closer to gets EU nod
Dr Reddy's Q1 net profit at Rs 1,392 cr
Dr Reddy's posts 1 pc drop in net profit at Rs 1,392 crore in Q1, revenue up 14 pc
Dr Reddy’s to sell Vonoprazan tablets in India
Dr Reddy’s, Sun Pharma recall drugs in US mkt
